US 11697689
Use of antibody against O-acetylated GD2 ganglioside to improve the therapeutic potential of drugs
granted A61KA61K2039/505A61K39/39558
Quick answer
US patent 11697689 (Use of antibody against O-acetylated GD2 ganglioside to improve the therapeutic potential of drugs) held by INSTITUT DE CANCEROLOGIE DE L'OUEST expires Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- INSTITUT DE CANCEROLOGIE DE L'OUEST
- Grant date
- Tue Jul 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/505, A61K39/39558, A61P, A61P35/00